slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 15,061-15,090
Pages 619
Rows per page 30
Component
15,061-15,090 of 18,554
310
The slide uses a specific scientific paper (Lin et al., 2007) to argue that the drug's mechanism is scientifically implausible based on the provided data.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
311
The slide uses expert testimony and raw data tables to challenge the validity of the reported pharmacokinetics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
317
The slide uses highlighted text to emphasize key admissions of quid pro quo arrangements.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
319
The slide uses a Q&A format to validate the thesis of extreme concentration in prescribing behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
320
The slide uses highlighted text to emphasize key admissions regarding prescription volume and the criminal nature of the speaker program.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
321
The slide uses a Q&A format to highlight the 'quid pro quo' nature of the speaker programs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
322
The slide presents a Q&A transcript excerpt highlighting a potential compliance issue regarding speaker programs and prescription volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a 'fraud-exposure' narrative by contrasting the official label with market reality.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses a Q&A transcript format to expose potentially fraudulent sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
328
The slide uses highlighted text to emphasize key allegations regarding pressure and compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
329
The slide uses a Q&A format to document unethical sales practices, specifically the verbal instruction to expand diagnoses to meet off-label sales goals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
331
The slide uses a Q&A format to highlight discrepancies in prescription volumes across similar-sized territories.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
332
The slide uses a Q&A format to present whistleblower testimony regarding unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
336
The slide uses a Q&A transcript format to highlight the 'weird' nature of the compensation process at Harmony.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
338
Includes direct Q&A transcript excerpts highlighting the alleged lack of transparency and short-term focus.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses a Q&A format to build a case for regulatory or ethical misconduct.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
343
The slide uses a combination of narrative summary and Q&A transcript to build a case of corporate malfeasance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
344
The slide uses a Q&A format to expose a scheme where management facilitates off-label marketing.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
345
The slide uses a Q&A format to document testimony regarding corporate fraud and off-label promotion.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
346
The slide uses a Q&A transcript format to substantiate claims of unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
347
The slide uses a Q&A transcript format to highlight the interviewee's cynical view on the prevalence of the disease.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
348
The slide uses a Q&A format to expose a potential business practice of incentivizing off-label drug prescriptions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
349
The slide uses a Q&A transcript format to build a case of fraudulent business practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
350
The slide uses highlighted text to emphasize key admissions of fraudulent behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
351
The slide uses a Q&A transcript format to highlight potential violations of the Stark Law.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
356
The slide uses Q&A format to present expert testimony regarding potential regulatory violations and mismanagement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
359
The slide uses a Q&A format to validate the thesis that high-volume prescribers quickly exhaust their patient pool and face insurance hurdles, contradicting potential growth narratives.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
363
The slide uses a Q&A format to validate the thesis of a slowing business.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
365
The slide uses direct Q&A transcripts to validate the thesis that the product has hit a growth ceiling.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
06
The slide functions as a detailed table of contents with summaries for each section.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit